Graham on SDI, Competitiveness

William R. Graham has directed the White House Office of Science and Technology Policy since Oct. 1, when the US. Senate approved his nomination to succeed George A. Keyworth II. Graham, whose background is largely in classified military systems research, had been serving as acting administrator of the National Aeronautics and Space Administration when President Reagan named him science adviser. A strong supporter of Reagan's 1980 presidential bid, Graham advised him on defense policy issues bot

Written byPeter Gwynne
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

A strong supporter of Reagan's 1980 presidential bid, Graham advised him on defense policy issues both before and after the election; he was a member of the transition team and served for three years as chairman of the president's General Advisory Committee on Arms Control and Disarmament. Graham is a former board member of the Committee on the Present Danger and has served on a number of advisory panels dealing with strategic military policy and nuclear warfare.

After obtaining a B.S. in physics from the California Institute of Technology and a Ph.D. in electrical engineering from Stanford University, Graham spent three years as an officer at the Air Force Weapons Laboratory in Albuquerque, N.M., directing research on strategic systems survivability. He then joined the Rand Corporation, a think tank on defense matters in Santa Monica, Calif. In 1971, he and some physicist colleagues formed their own consulting group, R&D Associates, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies